Therapeutic Advances In Drug Safety

Therapeutic Advances In Drug Safety

药物安全的治疗进展

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Therapeutic Advances In Drug Safety》是由SAGE出版社于2010年创办的英文国际期刊(ISSN: 2042-0986,E-ISSN: 2042-0994),该期刊长期致力于药学领域的创新研究,主要研究方向为Medicine-Pharmacology (medical)。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA开放获取模式(OA占比0.3636...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比82.81%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在64篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Therapeutic Advances In Drug Safety审稿周期约为9 Weeks。该刊近年未被列入国际预警名单,年发文量约64篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 64 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 149 / 356

58.3

学科:PHARMACOLOGY & PHARMACY SCIE Q2 135 / 356

62.22

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 105 / 354

70.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 160 / 354

54.94

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.6 SJR:0.833 SNIP:1.309
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q2 115 / 278

58%

期刊发文

  • Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS databas

    Author: Lv, Bo; Han, Junping; Yu, Yunli; Li, Yuedong

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261438241

  • Incidence, risk factors, and prediction model of piperacillin/tazobactam-associated hypokalemia in neonate

    Author: Wan, Jun; Lin, Shiteng; Zhuang, Wei; Chen, Weida; Huang, Yanting; Huang, Zhiyi; Lin, Wanlong; Chen, Yao

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261434697

  • Metformin-associated lactic acidosis in an elderly diabetic patient without classical risk factors: a case repor

    Author: Zheng, Yali; Sun, Jia; Zhang, Peng; Zhu, Quanfeng

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261428996

  • Drug-induced intestinal obstruction: insights from the FDA Adverse Event Reporting Syste

    Author: Li, He; Li, Yingjie; Liu, Lu; Zeng, Bing; Su, Sihui; Liu, Jianjian; Pan, Chun; Li, Tianlong

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986251414836

  • Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug-drug interaction study in liver transplant recipient

    Author: Li, Jieling; Li, Liubing; Xia, Yanzhe; Chen, Jie; Li, Jiali; Lin, Xiaobin; Chen, Xiao; Tang, Ke-Jing; Chen, Pan; Liu, Xiaoman

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261420282

  • Disparities and trends in drug-related adverse reaction mortality in the United States, 1999-202

    Author: Guo, Liwei; Dong, Xiuxun

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261421278

  • Effect of ciprofol-assisted sedation on tourniquet-related responses in foot and ankle surgery: a randomized clinical tria

    Author: Ma, Yaoyang; Zhu, Bingqing; Wang, Shudong; Lu, Danjun; Yan, Wenlong; Yu, Yi; Cao, Ying; Kang, Fang; Li, Juan

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986251414580

  • Pharmacovigilance analysis of secondary primary malignancies and antibiotic interactions in CAR-T cell therapie

    Author: Peng, Yun; Song, Yuxuan; Lin, Jiaxing; Qin, Caipeng; Du, Yiqing; Xu, Tao

    Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2025; Vol. 16, Issue , pp. -. DOI: 10.1177/20420986251340866